~~<i id='6D963AB434'><strike id='6D963AB434'><tt id='6D963AB434'><pre id='6D963AB434'></pre></tt></strike></i>~~

Home» focus» fashion

fashion

author：leisure time 2025-09-29 11:25:44 Page View：55155

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches
Next article： ChatGPT in medicine: STAT answers readers' burning questions

knowledge

Cancer drug shortages should be causing more outrage

DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

1:50HughJackmanandRyanReynoldsattendTheAdamProjectWorldPremiereatAliceTullyHall,Feb.28,2022,inNewYor

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

The aspartame in Diet Coke probably isn’t giving you cancer

NicholasHunt/GettyImagesThisessaywasoriginallypublishedonGideonMeyerowitz-Katz’sMediumblog.Aspartame